WHO advises against Gilead's remdesivir for all hospitalised COVID-19 patients
Source: Reuters
LONDON (Reuters) - Gileads drug remdesivir is not recommended for patients hospitalised with COVID-19, regardless of how ill they are, as there is no evidence it improves survival or reduces the need for ventilation, a World Health Organization panel said on Friday.
The ... panel found a lack of evidence that remdesivir improved outcomes that matter to patients such as reduced mortality, need for mechanical ventilation, time to clinical improvement, and others, the guideline said.
The advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for COVID-19 in the summer after early trials showed some promise.
At the end of October, Gilead cut its 2020 revenue forecast, citing lower-than-expected demand and difficulty in predicting sales of remdesivir.
-snip-
November 19, 2020 8:06 PM Updated 42 minutes ago
By Kate Kelland
Read more: https://www.reuters.com/article/us-health-coronavirus-remdesivir-who/who-advises-against-gileads-remdesivir-for-all-hospitalised-covid-19-patients-idUSKBN28000Q
KWR65
(1,098 posts)There is no vaccine or cure for covid-19
PSPS
(13,588 posts)Remdesivir was always intended as a treatment to help alleviate some symptoms, not a vaccine or a "cure."
There are at least three very promising vaccines in the pipeline that potentially could be of great help in knocking it out after a period ot time, although the full results of their clinical trials haven't yet been released and reviewed. So far, at least, they look very promising to many, including Dr. Fauci.
still_one
(92,116 posts)stay.
They use it for something it was never intended, and then say see it doesnt work for something it wasnt intended to do.
and you are right about vaccines also. Vaccines are not a cure but a preventive, and the efficacy of two leading messenger RNA vaccines have demonstrated a 95% efficacy which is quite remarkable
They still dont now how long the protection lasts, and other things, but it is very promising as you said
Bernardo de La Paz
(48,988 posts)kiri
(794 posts)discovered a link between fluvoxamine, an antidepressant, and sepsis, when the immune system creates too many inflammatory molecules.
administering the antidepressant could prevent serious complications with COVID, thought to occur from cytokine storms. They displayed impressive findings after a small clinical trial.